OPTIBIOTIX HEALTH PLC Logo

OPTIBIOTIX HEALTH PLC

OPTI | IL

Overview

Corporate Details

ISIN(s):
GB00BP0RTP38
LEI:
213800UKYQFT941QHS14
Country:
United Kingdom
Address:
Innovation Centre Innovation Way, YO10 5DG York
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

OptiBiotix Health PLC is a life sciences company specializing in the research and development of technologies that modulate the human microbiome. The company identifies and develops microbial strains, compounds, and formulations for use as food ingredients and supplements. Its core focus is on the prevention and management of chronic lifestyle diseases, including obesity, hypercholesterolemia (high cholesterol), and diabetes. The company's approach is underpinned by scientific research and human clinical studies, delivering proprietary ingredients like SlimBiome® and LPLDL® as well as white-label product solutions to its commercial partners.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for OPTIBIOTIX HEALTH PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-21 08:00
Delisting Announcement
Admission to Trading on the OTCQB Venture Market
English 14.4 KB
2025-08-20 08:00
Regulatory News Service
Agreement with Weight Management Company
English 15.1 KB
2025-08-14 08:00
Regulatory News Service
Launch of SlimBiome in leading US brand
English 17.0 KB
2025-08-06 17:08
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
English 13.9 KB
2025-08-06 08:00
Share Issue/Capital Change
Issue of Options
English 31.2 KB
2025-07-28 08:00
Earnings Release
Trading update
English 19.1 KB
2025-06-30 08:00
Earnings Release
Final Results
English 544.3 KB
2025-06-30 08:00
Regulatory News Service
Change of Broker
English 11.6 KB
2025-06-11 08:00
Environmental & Social Information
SlimBiome® study in European Journal of Nutrition
English 28.0 KB
2025-05-23 08:00
Share Issue/Capital Change
Placing and Issue of Warrants
English 20.6 KB
2025-03-18 08:00
Business and Financial Review
Commercial Update
English 35.7 KB
2025-02-18 08:00
Regulatory News Service
Launch of Daily Nouri FeelFull product in America
English 18.4 KB
2025-01-20 08:00
Business and Financial Review
Launch of products on Amazon India
English 15.9 KB
2025-01-08 08:00
Board/Management Information
Directorate Change
English 18.4 KB
2024-12-20 13:00
Related Party Transaction
Issue of Options
English 32.5 KB

Automate Your Workflow. Get a real-time feed of all OPTIBIOTIX HEALTH PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for OPTIBIOTIX HEALTH PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN